These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Erythroleukemia in the adjuvant treatment of breast cancer. Lichtman SM; Schulman P; Budman DR N Y State J Med; 1985 Oct; 85(10):601-3. PubMed ID: 3866166 [No Abstract] [Full Text] [Related]
23. [Can cytostatic agents cause cancer?]. Schaberg A; Gorsira MC Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1433-5. PubMed ID: 4506858 [No Abstract] [Full Text] [Related]
25. Antineoplastic agents--action and toxicities. Rogers B AAOHN J; 1986 Nov; 34(11):530-8. PubMed ID: 3640629 [No Abstract] [Full Text] [Related]
26. Chemical carcinogenesis: a view at the end of the first half-century. Coombs MM J Pathol; 1980 Feb; 130(2):117-46. PubMed ID: 6988556 [No Abstract] [Full Text] [Related]
27. [Cancerogenicity of cytostatics]. Schmähl D; Osswald H Dtsch Med Wochenschr; 1971 Oct; 96(43):1696. PubMed ID: 5099202 [No Abstract] [Full Text] [Related]
28. Delayed consequences of cancer therapy: proven and potential. Basic mechanisms. Cancer; 1976 Feb; 37(2 Suppl):999-1013. PubMed ID: 1253134 [No Abstract] [Full Text] [Related]
29. [Tumor-causing drugs used in clinical medicine]. Feo F Minerva Med; 1979 Feb; 70(6):503-6. PubMed ID: 431871 [No Abstract] [Full Text] [Related]
30. [On ways of reducing the toxic effects of antitumorous preparations]. Monakhov BV Vopr Onkol; 1968; 14(8):101-12. PubMed ID: 4301862 [No Abstract] [Full Text] [Related]
31. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds]. Kholodnyi MD; Mindlin SS Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329 [No Abstract] [Full Text] [Related]
33. [Life expectancy of erythrocytes under the influence of the cytostatic 2,3,5-tris-ethyleniminobenzoquinone-(1,4) and the anabolic methenolone enanthate]. Strubelt O Arzneimittelforschung; 1965 Sep; 15(9):1051-4. PubMed ID: 5898692 [No Abstract] [Full Text] [Related]
34. [Pseudomembranous-necrotizing colitis following treatment with cytostatic drugs]. Bauer M Zentralbl Allg Pathol; 1966; 109(5):516-9. PubMed ID: 5300165 [No Abstract] [Full Text] [Related]
35. [Ophthalmologic side effects of the use of cytostatic agents]. Zaal MJ; Polak BC Ned Tijdschr Geneeskd; 1985 Oct; 129(40):1919-21. PubMed ID: 4069251 [No Abstract] [Full Text] [Related]
36. Limitations of oral busulfan in preparative regimen before hematopoietic stem-cell transplantation. Kami M; Hamaki T; Maruta Y; Miyakoshi S; Mutou Y Haematologica; 2002 Feb; 87(2):ELT10. PubMed ID: 11836187 [No Abstract] [Full Text] [Related]
37. Nephrotoxicities of antineoplastic and immunosuppressive agents. Raymond JR Curr Probl Cancer; 1984 Oct; 8(16):1-32. PubMed ID: 6238806 [No Abstract] [Full Text] [Related]
38. [The problem of chemical mutagenesis in man]. Gebhardt E Folia Clin Int (Barc); 1968; 18(7):396-408. PubMed ID: 5746822 [No Abstract] [Full Text] [Related]
40. [Side effects of antineoplastic agents used in combination with surgical operations, with reference to bone marrow disorders]. Akagi M; Zaitsu S; Anzai S; Kiyomoto A; Mori K Gan No Rinsho; 1966 Oct; 12(10):628-34. PubMed ID: 6009336 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]